SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-008068
Filing Date
2024-05-14
Accepted
2024-05-14 08:09:31
Documents
67
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q xlo-20240331x10q.htm   iXBRL 10-Q 1555453
2 EX-10.1 xlo-20240331xex10d1.htm EX-10.1 790958
3 EX-10.2 xlo-20240331xex10d2.htm EX-10.2 275288
4 EX-10.3 xlo-20240331xex10d3.htm EX-10.3 143789
5 EX-10.6 xlo-20240331xex10d6.htm EX-10.6 16392
6 EX-31.1 xlo-20240331xex31d1.htm EX-31.1 13366
7 EX-31.2 xlo-20240331xex31d2.htm EX-31.2 13245
8 EX-32.1 xlo-20240331xex32d1.htm EX-32.1 7848
  Complete submission text file 0001558370-24-008068.txt   6988965

Data Files

Seq Description Document Type Size
9 EX-101.SCH xlo-20240331.xsd EX-101.SCH 38922
10 EX-101.CAL xlo-20240331_cal.xml EX-101.CAL 33204
11 EX-101.DEF xlo-20240331_def.xml EX-101.DEF 183864
12 EX-101.LAB xlo-20240331_lab.xml EX-101.LAB 352979
13 EX-101.PRE xlo-20240331_pre.xml EX-101.PRE 308308
71 EXTRACTED XBRL INSTANCE DOCUMENT xlo-20240331x10q_htm.xml XML 616002
Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Filer) CIK: 0001840233 (see all company filings)

IRS No.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40925 | Film No.: 24941529
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)